160 related articles for article (PubMed ID: 21664289)
1. Acute myeloid leukemia: a central role for the ETS factor ERG.
Martens JH
Int J Biochem Cell Biol; 2011 Oct; 43(10):1413-6. PubMed ID: 21664289
[TBL] [Abstract][Full Text] [Related]
2. The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia.
Sotoca AM; Prange KH; Reijnders B; Mandoli A; Nguyen LN; Stunnenberg HG; Martens JH
Oncogene; 2016 Apr; 35(15):1965-76. PubMed ID: 26148230
[TBL] [Abstract][Full Text] [Related]
3. PU.1: a crucial and versatile player in hematopoiesis and leukemia.
Kastner P; Chan S
Int J Biochem Cell Biol; 2008; 40(1):22-7. PubMed ID: 17374502
[TBL] [Abstract][Full Text] [Related]
4. The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells.
Loughran SJ; Kruse EA; Hacking DF; de Graaf CA; Hyland CD; Willson TA; Henley KJ; Ellis S; Voss AK; Metcalf D; Hilton DJ; Alexander WS; Kile BT
Nat Immunol; 2008 Jul; 9(7):810-9. PubMed ID: 18500345
[TBL] [Abstract][Full Text] [Related]
5. PU.1: An ETS family transcription factor that regulates leukemogenesis besides normal hematopoiesis.
Gupta P; Gurudutta GU; Verma YK; Kishore V; Gulati S; Sharma RK; Chandra R; Saluja D
Stem Cells Dev; 2006 Aug; 15(4):609-17. PubMed ID: 16978063
[TBL] [Abstract][Full Text] [Related]
6. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia.
Diffner E; Beck D; Gudgin E; Thoms JA; Knezevic K; Pridans C; Foster S; Goode D; Lim WK; Boelen L; Metzeler KH; Micklem G; Bohlander SK; Buske C; Burnett A; Ottersbach K; Vassiliou GS; Olivier J; Wong JW; Göttgens B; Huntly BJ; Pimanda JE
Blood; 2013 Mar; 121(12):2289-300. PubMed ID: 23327922
[TBL] [Abstract][Full Text] [Related]
7. Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis.
Gangenahalli GU; Gupta P; Saluja D; Verma YK; Kishore V; Chandra R; Sharma RK; Ravindranath T
Stem Cells Dev; 2005 Apr; 14(2):140-52. PubMed ID: 15910240
[TBL] [Abstract][Full Text] [Related]
8. The PU.1-Modulated MicroRNA-22 Is a Regulator of Monocyte/Macrophage Differentiation and Acute Myeloid Leukemia.
Shen C; Chen MT; Zhang XH; Yin XL; Ning HM; Su R; Lin HS; Song L; Wang F; Ma YN; Zhao HL; Yu J; Zhang JW
PLoS Genet; 2016 Sep; 12(9):e1006259. PubMed ID: 27617961
[TBL] [Abstract][Full Text] [Related]
9. Genome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia.
Goldberg L; Tijssen MR; Birger Y; Hannah RL; Kinston SJ; Schütte J; Beck D; Knezevic K; Schiby G; Jacob-Hirsch J; Biran A; Kloog Y; Marcucci G; Bloomfield CD; Aplan PD; Pimanda JE; Göttgens B; Izraeli S
Blood; 2013 Oct; 122(15):2694-703. PubMed ID: 23974202
[TBL] [Abstract][Full Text] [Related]
10. The oncogenic role of the ETS transcription factors MEF and ERG.
Sashida G; Bazzoli E; Menendez S; Liu Y; Nimer SD
Cell Cycle; 2010 Sep; 9(17):3457-9. PubMed ID: 20814243
[TBL] [Abstract][Full Text] [Related]
11. ERG is a megakaryocytic oncogene.
Salek-Ardakani S; Smooha G; de Boer J; Sebire NJ; Morrow M; Rainis L; Lee S; Williams O; Izraeli S; Brady HJ
Cancer Res; 2009 Jun; 69(11):4665-73. PubMed ID: 19487285
[TBL] [Abstract][Full Text] [Related]
12. High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.
Marcucci G; Maharry K; Whitman SP; Vukosavljevic T; Paschka P; Langer C; Mrózek K; Baldus CD; Carroll AJ; Powell BL; Kolitz JE; Larson RA; Bloomfield CD;
J Clin Oncol; 2007 Aug; 25(22):3337-43. PubMed ID: 17577018
[TBL] [Abstract][Full Text] [Related]
13. Early lineage priming by trisomy of Erg leads to myeloproliferation in a Down syndrome model.
Ng AP; Hu Y; Metcalf D; Hyland CD; Ierino H; Phipson B; Wu D; Baldwin TM; Kauppi M; Kiu H; Di Rago L; Hilton DJ; Smyth GK; Alexander WS
PLoS Genet; 2015 May; 11(5):e1005211. PubMed ID: 25973911
[TBL] [Abstract][Full Text] [Related]
14. The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia.
Coskun E; von der Heide EK; Schlee C; Kühnl A; Gökbuget N; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
Leuk Res; 2011 Feb; 35(2):208-13. PubMed ID: 20570349
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of miR-9/9* in myeloid progenitors inhibits neutrophil differentiation by post-transcriptional regulation of ERG.
Nowek K; Sun SM; Bullinger L; Bindels EM; Exalto C; Dijkstra MK; van Lom K; Döhner H; Erkeland SJ; Löwenberg B; Jongen-Lavrencic M
Leukemia; 2016 Jan; 30(1):229-37. PubMed ID: 26174629
[TBL] [Abstract][Full Text] [Related]
16. ETS-related gene ERG expression in AML patients is significantly associated with NPM1 mutation status.
Hämäläinen M; Juvonen V; Häikiö S; Lakkala T; Johansson J; Pelliniemi TT; Salmi TT; Remes K; Kairisto V
Eur J Haematol; 2010 Oct; 85(4):361-2. PubMed ID: 20546020
[No Abstract] [Full Text] [Related]
17. c-Myb and Ets proteins synergize to overcome transcriptional repression by ZEB.
Postigo AA; Sheppard AM; Mucenski ML; Dean DC
EMBO J; 1997 Jul; 16(13):3924-34. PubMed ID: 9233802
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of Erg and Ets-2 transcription factors is associated with genetic changes at 21q22.2-22.3 in immortal and cervical carcinoma cell lines.
Simpson S; Woodworth CD; DiPaolo JA
Oncogene; 1997 May; 14(18):2149-57. PubMed ID: 9174050
[TBL] [Abstract][Full Text] [Related]
19. Mouse models in the study of the Ets family of transcription factors.
Bartel FO; Higuchi T; Spyropoulos DD
Oncogene; 2000 Dec; 19(55):6443-54. PubMed ID: 11175360
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERG.
Mochmann LH; Bock J; Ortiz-Tánchez J; Schlee C; Bohne A; Neumann K; Hofmann WK; Thiel E; Baldus CD
Oncogene; 2011 Apr; 30(17):2044-56. PubMed ID: 21242973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
